Medicinal Products

DEXERYLCARE

Generic drug of the therapeutic class: Dermatology
Active ingredients: [Other Ã~mollients and protectors, 4491]
laboratory: Pierre Fabre Medicament

CrÞme
500 g pump bottle
All forms

Indication

Treatment of cutaneous dryness associated with certain dermatoses such as atopic dermatitis and ichthyosis. A medical opinion is necessary to make the initial diagnosis of these dermatoses.

Dosage DEXERYLCARE cream bottle 500 g pump

Treatment of cutaneous dryness associated with certain dermatoses such as atopic dermatitis and ichthyosis. A medical opinion is necessary to make the initial diagnosis of these dermatoses.

Against indications

Hypersensitivity to the active substances or to any of the excipients listed under Composition .

Dexerylcare side effects

The following undesirable effects have been reported in clinical studies and since the marketing of this medicinal product:

Very often (≥1 / 10)

Frequent (≥1 / 100 to "<1/10)

Not very frequent (≥1 / 1, 000 to <1/100)

Rare (≥1 / 10, 000 to "<1/1000)

Very rare (<1 / 10, 000)

Frequency unknown (can not be estimated based on available data).

Class of organ systems

Frequencies of undesirable effects

Not very frequent

Unknown frequency

Skin and subcutaneous tissue disorders

Urticaria, contact dermatitis, eczÚma, ÚrythÞme, pruritus, rash

burning sensation of the skin, tingling sensation of the skin

General disorders and administration site abnormalities

irritation, redness, pain, itching

eczÚma at the application site

Declaration of suspected undesirable effects

The declaration of undesirable effects suspected after authorization of the drug is important. It allows continuous monitoring of the beneficial / risk ratio of the drug. Healthcare professionals declare any suspected adverse effects via the national system of declaration: National Agency for the Safety of Medicines and Health Products (ANSM) and the Network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article